IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 46.87

Change

-0.20 (-0.42)%

Market Cap

N/A

Volume

0.56M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-14 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-3.10 (-2.35%)

USD 35.08B
FHLC Fidelity® MSCI Health Care In..

-1.34 (-2.15%)

USD 2.50B
FXH First Trust Health Care AlphaD..

-1.16 (-1.14%)

USD 0.89B
XHE SPDR® S&P Health Care Equipme..

-0.93 (-1.12%)

USD 0.16B
IDNA iShares Genomics Immunology an..

-0.19 (-0.98%)

USD 0.10B
XHS SPDR® S&P Health Care Service..

-0.70 (-0.71%)

USD 0.09B
SBIO ALPS Medical Breakthroughs ETF

-0.39 (-1.43%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.70 (-2.55%)

USD 0.04B
BBP Virtus LifeSci Biotech Product..

-0.78 (-1.44%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

-0.39 (-2.21%)

USD 0.01B

ETFs Containing IHF

MSSS Northern Lights Fund Trus.. 9.23 % 0.00 %

-0.09 (-0.31%)

USD 0.08B
LCR Managed Portfolio Series 1.82 % 0.00 %

-0.07 (-0.31%)

USD 0.07B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.33% 90% A- 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.33% 90% A- 36% F
Trailing 12 Months  
Capital Gain -12.60% 25% F 21% F
Dividend Return 0.57% 56% F 9% A-
Total Return -12.03% 25% F 19% F
Trailing 5 Years  
Capital Gain 22.88% 71% C- 41% F
Dividend Return 5.31% 63% D 10% F
Total Return 28.19% 62% D 33% F
Average Annual (5 Year Horizon)  
Capital Gain 2.53% 62% D 47% F
Dividend Return 3.18% 62% D 40% F
Total Return 0.64% 63% D 16% F
Risk Return Profile  
Volatility (Standard Deviation) 19.25% 43% F 52% F
Risk Adjusted Return 16.50% 57% F 35% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.